← All Silexion Therapeutics CORP filings

Silexion Therapeutics CORP Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
SLXN
Silexion Therapeutics CORP
SCHEDULE: Moringa Sponsor Disputes Silexion Share Issuance
Moringa Sponsor, LP filed an amendment to its Schedule 13D, formally disputing the validity of recent share issuances by Silexion Therapeutics Corp.
NASDAQ
SLXN
Silexion Therapeutics CORP
SCHEDULE: Silexion Share Dispute: Investor Challenges $1.8M Conversion
Moringa Sponsor, LP disputes the validity of 450,000 ordinary shares issued by Silexion Therapeutics Corp from a $1.8 million debt conversion.
NASDAQ
SLXN
Silexion Therapeutics CORP
SCHEDULE 13D/A: Wildcat Capital's Stake in Silexion Therapeutics Diluted to 1.3% Amid Increased Outstanding Shares
Wildcat Capital Management, LLC and its affiliates have reported a decreased beneficial ownership percentage in Silexion Therapeutics Corp to 1.3% due to an increase in the issuer's outstanding ordinary shares.